PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Leumit HMO, Medical Division, Tel-Aviv, Israel.\', \'Department of Family Medicine, Sackler Faculty of Medicine, Tel Aviv University.\', \'Leumit HMO, Central District Headquarter, Netanya, Israel.\', \'The Pesach Segal Israeli Center for Diabetes Research and Policy, Sheba Medical Center, Ramat Gan, Israel.\', \'Diabetes Medical Center, Tel Aviv, Israel.\', \'Diabetes Unit, Institute of Endocrinology, Metabolism and Hypertension, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel.\', \'The Sackler Faculty of Medicine Tel-Aviv University, Israel.\']
?:citedBy
  • -1
?:creator
?:hasPublicationType
?:journal
  • Harefuah
is ?:pmid of
?:pmid
?:pmid
  • 34689433
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.13
?:rankingScore_hIndex
  • 16
is ?:relation_isRelatedTo_publication of
?:title
  • [HEMOGLOBIN A1C AND MORTALITY FROM COVID-19].
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all